10x Genomics (TXG) Gross Profit (2018 - 2026)

10x Genomics' Gross Profit history runs 9 years deep, the most recent figure standing at $106.2 million for Q1 2026.

• In Q1 2026, Gross Profit rose 0.7% year-over-year to $106.2 million; the TTM figure through Mar 2026 stood at $444.6 million (up 4.12% YoY), while the FY2025 annual figure was $443.9 million, up 7.09% from the prior year.
• Gross Profit came in at $106.2 million for Q1 2026 at 10x Genomics, down from $113.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $125.1 million in Q2 2025 to a low of $86.9 million in Q2 2022.
• A 5-year average of $104.1 million and a median of $104.2 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit decreased 21.66% in 2022 and climbed 20.02% in 2025, its largest moves.
• 10x Genomics' Gross Profit stood at $119.4 million in 2022, then fell by 3.03% to $115.8 million in 2023, then declined by 4.17% to $111.0 million in 2024, then rose by 1.88% to $113.0 million in 2025, then dropped by 6.07% to $106.2 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $106.2 million, $113.0 million, and $100.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison